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ABSTRACT
Guanine-rich DNA sequences can form G-quadru-
plexes stabilized by stacked G–G–G–G tetrads in
monovalent cation-containing solution. The length
and number of individual G-tracts and the length
and sequence context of linker residues define the
diverse topologies adopted by G-quadruplexes.
The review highlights recent solution NMR-based
G-quadruplex structures formed by the four-repeat
human telomere in K
+ solution and the guanine-rich
strands of c-myc, c-kit and variant bcl-2 oncogenic
promoters, as well as a bimolecular G-quadruplex
that targets HIV-1 integrase. Such structure deter-
minations have helped to identify unanticipated
scaffolds such as interlocked G-quadruplexes, as
well as novel topologies represented by double-
chain-reversal and V-shaped loops, triads, mixed
tetrads, adenine-mediated pentads and hexads and
snap-back G-tetrad alignments. The review also
highlights the recent identification of guanine-rich
sequences positioned adjacent to translation start
sites in 5’-untranslated regions (5’-UTRs) of RNA
oncogenic sequences. The activity of the enzyme
telomerase, which maintains telomere length, can
be negatively regulated through G-quadruplex for-
mation at telomeric ends. The review evaluates
progress related to ongoing efforts to identify
small molecule drugs that bind and stabilize distinct
G-quadruplex scaffolds associated with telomeric
and oncogenic sequences, and outlines progress
towards identifying recognition principles based
on several X-ray-based structures of ligand–G-
quadruplex complexes.
INTRODUCTION
DNA can adopt structures other than the Watson–Crick
duplex when actively participating in replication,
transcription, recombination and damage repair.
Of particular interest are guanine-rich regions, which
can adopt a non-canonical four-stranded topology called
the G-quadruplex. Such architectures are adopted in
several key biological contexts, including DNA telomere
ends, the purine-rich DNA strands of oncogenic promoter
elements, and within RNA 50-untranslated regions (UTR)
in close proximity to translation start sites. Therefore, eluci-
dation of the sequence-based diversity of G-quadruplex
scaﬀolds could provide insights into the distinct biology of
guanine-rich sequences within the genome.
Guanine-rich DNA G-quadruplexes
G-quadruplexes are built from the stacking of successive
G–G–G–G tetrads (G-tetrads) and stabilized by bound
monovalent Na
+ and K
+ cations (1). The G-tetrad is a
cyclic hydrogen-bonded square planar alignment of four
guanines (Figure 1a), with the guanines adopting either
anti or syn alignments about glycosidic bonds (Figure 1b
and c, respectively). G-quadruplexes are very stable, with
their large diameter and four grooves deﬁning a unique
architecture (2) that is distinct from duplex DNA.
The backbone strands (or columns) that constitute the
stacked G-tetrad core of the G-quadruplex can adopt
diﬀerent directionalities. Furthermore, the relative strand
directionalities are geometrically related with the glycosi-
dic conformation of the guanines. There are four
possibilities: (i) Four strands are oriented in the same
direction; the glycosidic angles around the G-tetrad are
anti–anti–anti–anti (3–5), and occasionally syn–syn–syn–
syn (6). (ii) Three strands are oriented in one direction
and the fourth is oriented in the opposite direction;
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syn–syn (7). (iii) Two neighboring strands are oriented in
one direction and the two remaining strands oriented in
the opposite direction (as a result of which each strand has
both parallel and anti-parallel adjacent neighbors); the
glycosidic angles are syn–syn–anti–anti (8–10). (iv) Each
strand has adjacent anti-parallel neighbors; the glycosidic
angles are syn–anti–syn–anti (11–14).
Loops in G-quadruplexes are linkers connecting G-rich
tracts that support the stacked G-tetrad core. The loops
can be classiﬁed into four major families that depend in
part on the size and sequence of the linkers: (i) Edge-wise
or lateral loops connect two adjacent anti-parallel strands
(Figure 2a), and are generally composed of two or more
residues (9,15). (ii) Diagonal loops connect two opposing
anti-parallel strands (Figure 2b) (8–10), and are generally
composed of three or more residues. (iii) Double-chain-
reversal or propeller loops connect adjacent parallel
strands (Figure 2c) (7,16,17), and can be as small as one
and as large as six or more residues. The adenine in single-
residue double-chain-reversal loops that bridge two
G-tetrad planes can form hydrogen bonds with one edge
of the G-tetrad resulting in A–(G–G–G–G) pentad forma-
tion (18) or two opposing edges of the G-tetrad resulting
in A–(G–G–G–G)–A hexad formation (16). (iv) V-shaped
loops connecting two corners of a G-tetrad core in which
a support column is missing (Figure 2d) (18).
Furthermore, loop residues can form base-pairing
alignments, which in turn stack with the terminal
G-tetrads, further stabilizing G-quadruplex structures.
These include three bases in a plane, which can be
classiﬁed either as base triples, where all three bases are
non-contiguous in the sequence, or as base triads (19),
where two adjacent bases from one strand are involved in
the pairing alignment with a base from a second strand
(20). Loop conformations can adopt diverse topologies
(21,22) making them attractive targets for small molecule-
based ligand recognition.
The G-quadruplex topology is deﬁned by four grooves
whose dimensions (depth and width) and accessibility vary
based on both the overall topology and whether the loops
are edge-wise or diagonal on one hand, and double-chain-
reversal on the other. G-quadruplex formation requires
monovalent cations, which are positioned within the
central channel of stacked G-tetrads, thereby neutralizing
the strong electrostatic potential associated with the
inwardly pointing guanine O
6 oxygen (23). The dehy-
drated cations are positioned either in a tetragonal
bipyramidal coordination between G-tetrads planes
(K
+) (Figure 1d) (10), or in a range of geometries that
span positioning within G-tetrad planes to out of plane
alignments (Na
+) (24). It has been shown that in general
G-quadruplexes prefer K
+ over Na
+, and that this
reﬂects in part the much greater energetic penalty for
Na
+ dehydration (25). Finally, the same sequence can
adopt diﬀerent G-quadruplex conformations in Na
+ (14)
and K
+ (26) solution as determined by NMR, and also as
monitored by ﬂuorescently labeled oligonucleotides (27).
The subject of G-quadruplexes has been extensively
reviewed in the literature (28–38). Despite a wealth of
crystal and solution structures, it has proved diﬃcult to
deﬁne a comprehensive set of rules that specify the folding
propensity of G-quadruplexes. Therefore, each new
guanine-rich telomeric and oncogenic promoter sequence
has to be individually structurally characterized as a
function of monovalent cation type and, in addition,
checked for conformational heterogeneity between two
or more topologies in solution.
This review presents a structural biology perspective of
recent advances in structures of G-quadruplexes formed by
human telomeric and oncogenic promoter G-rich tracts, as
well as the potential of small molecules to target-speciﬁc
G-quadruplex folds, thereby setting the stage for structure-
based design of new classes of cancer therapeutics. The
review also highlights the increasing attention being focused
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Figure 2. Schematic illustrating (a) edge-wise, (b) diagonal, (c) double-
chain-reversal or propeller and (d) V-shaped loops. The loops connect
individual strands or columns bridging two G-tetrad planes. Color-
coding for schematics is as follows: anti guanines in blue and syn guanines
in magenta. G-rich columns in black and connecting loops in red.
(b) (c)
(a)
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Figure 1. (a) Schematic alignment of four guanines in a plane to form
the G–G–G–G tetrad (G-tetrad). Each guanine uses its Watson–Crick
and major groove edges to form a pair of hydrogen bonds. This leaves
the minor groove edge available for further recognition. Schematic
illustrating (b) anti and (c) syn guanine glycosidic torsion angle
alignments. The H8 and sugar H10 protons are closer to each other
(2.5A ˚ ) in the syn alignment compared to a longer distance (3.7A ˚ )i n
the anti alignment, a feature that can be readily monitored by NMR
(256). (d) Two views of K
+ cation-coordination between adjacent
G-tetrad planes. Each tetrad provides four inwardly pointing guanine
carbonyls, such that the dehydrated K
+ cation participates in a directly
coordinated tetragonal bipyramidal arrangement (10).
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Biology of guanine-rich genomic sequences
Guanine-rich tracts are observed in critical segments of
eukaryotic and prokaryotic genomes, promoter regions,
both short microsatellite and longer minisatellite repeats,
ribosomal DNAs, as well as telomeres in eukaryotes and
immunoglobulin heavy chain switch regions of higher
vertebrates. These guanine-rich tracts have the potential to
form G-quadruplexes following transient destabilization
of the duplex, a process that accompanies transcription,
replication and recombination. Systematic algorithmic
searches of bacterial and human genomes for guanine-
rich tracts (restricted to minimum of four GGG segments
separated by short linkers) (39–41) have noted that such
putative G-quadruplex-forming sequences are prevalent
in proto-oncogenes (which promote cell proliferation)
and essentially lacking in tumor-suppressor genes
(which maintain genomic stability) (42).
An increasing number of proteins have been iden-
tiﬁed that bind, promote or non-catalytically disrupt
G-quadruplex formation (43–46). Both the b-subunit
of the Oxytricha telomere end-binding protein (bTBP)
(47) and repressor activator protein 1 (RAP1) in
Saccharomyces cerevisiae (48) promote intermolecular
G-quadruplex formation. In addition, the MutSa protein,
involved in mismatch repair, targets G-quadruplex DNA
in G-loop segments and promotes synapsis of transcrip-
tionally activated immunoglobulin switch regions (49).
Activation-induced cytosine deaminase (AID) also targets
G-quadruplex DNA and plays a role in immunoglobulin
class switch recombination (50). On the other hand,
binding of POT1, a protein conserved from ﬁssion yeast to
humans (51), disrupts G-quadruplex formation at telo-
meric G-rich overhangs (52), thereby promoting telomere
extension by telomerase (53).
In addition, helicases catalytically unwind and nucleases
cleave G-quadruplexes (43–46). RecQ DNA helicase
family members are associated with genomic instability
and predisposition to malignancies. The Bloom and
Werner syndrome RecQ helicases bind to (54) and
unwind intermolecular G-quadruplex scaﬀolds with a
30 to 50 polarity in the presence of ATP and Mg cations
(55,56). Furthermore, G-quadruplex-speciﬁc nucleases cut
within single-stranded DNA several nucleotides upstream
of the G-quadruplex using a structure-speciﬁc mode of
action (57–60). Gene disruption of such nucleases can lead
to cellular senescence and telomere shortening (61). Such
cleavage may also be required for DNA recombination
and suggests that DNA quadruplexes may play a role in
the formation of interchromosomal synapsis.
Strong evidence supporting G-quadruplex formation
in vivo comes from the demonstration that in vitro
generated single-chain antibody fragments speciﬁc for
intermolecular telomeric G-quadruplex DNA react with
ciliated protozoan Stylonychia lemnae macronuclei but not
corresponding micronuclei (62). Additional evidence in
support of G-quadruplex formation in vivo comes from the
observation that telomere end-binding proteins control the
formation of G-quadruplex DNA structures in vivo (63)
and that intracellular transcription of G-rich DNAs
induces formation of G-loops, novel structures containing
G-quadruplex DNA on the non-template G-rich strand,
as veriﬁed from nucleolin binding and sensitivity
to G-quadruplex-speciﬁc nucleases (64). In addition,
attempts have been made to monitor G-quadruplex forma-
tion at telomere proximal regions of chromosomal DNA
using G-quadruplex-speciﬁc ﬂuorescent 3,6-bis(1-methyl-
4-vinylpyridinium) carbazole diiodide (BMVC) (65).
Furthermore, it has been proposed that gene function
correlates with potential for G-quadruplex formation in
the human genome (42). Both inter- and intramolecular
G-quadruplex formation has also been demonstrated for
the diabetes susceptibility locus in the promoter region of
the human insulin gene (66). Finally, guanine-rich tracts
containing sequences capable of G-quadruplex formation
have been shown to induce apoptosis in tumor cells (67–69).
In addition, guanine-rich RNA sequences capable of
G-quadruplex formation have been identiﬁed in the
vicinity of polyadenylation regions (70) involved in
regulating 30-end processing of mammalian pre-mRNAs
(71). Such guanine-rich motifs can interact with hnRNP H
protein subfamily members, thereby potentially mediating
alternative, tissue-speciﬁc splicing events. There also
appears to be a combinatorial code for splicing silencing
which includes a combination of RNA UAGG and
GGGG motifs (72). There are several examples of RNA
G-quadruplex complexes that impact on pathways ran-
ging from RNA processing, as in the case of the
exoribonuclease mXRN1p (73), to translational repres-
sion, as in the case of the fd gene 5 protein (74). Guanine-
rich tracts have also been observed within neuronal RNAs
that bind the RGG-rich domain of the fragile X mental
retardation (FXMR) protein (75,76).
HUMAN TELOMERIC G-QUADRUPLEXES
Telomeres, nucleoprotein complexes located at the ends of
eukaryotic chromosomes, are composed of tandem DNA
repeats of guanine-rich sequences (77). Telomeres are
essential for chromosomal stability and genomic integrity,
provide sites for recombination events and transcriptional
silencing, and appear to play a critical role in cellular
aging and cancer (43,78–81). Telomeric DNA ends are
composed of both duplex and guanine-rich 30-overhang
segments, with the former progressively decreasing in
length after each round of cell division in somatic cells
(82). By contrast, telomeric overhangs can be elongated by
the enzyme telomerase, a ribonucleoprotein complex with
reverse transcriptase activity (83), which is expressed in the
majority of cancer cells, thereby helping to maintain
telomere length (84).
The pairing of homologous chromatids at their telomere
ends can be mediated through bimolecular quadruplex
formation (11). Such quadruplex structures may also play
a role in chromosome synapsis and recombination during
meiosis (85).
The guanine-rich 30-overhangs of telomeres, such as
TTAGGG repeats in humans can equilibrate between
single-stranded and monovalent cation-mediated
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of telomerase. The telomeric ends in a single-stranded form
are maintained by hPOT1 (86), while disruption of this
interaction leads to quadruplex formation. Thus, ligand-
induced stabilization of telomeric G-quadruplex scaﬀolds in
humans constitutes a promising strategy for anti-cancer
drug development (87–91). Therefore, much eﬀort has been
devoted to the structural characterization of G-quadruplex
topologies formed by one, two, three and four human
telomeric TTAGGG repeats as a function of monovalent
cation, so as to deﬁne the scaﬀolds for anti-cancer drug
discovery.
Though extensive studies have been undertaken on both
ciliate (Tetrahymena and Oxytricha) and eukaryotic (yeast
and human) telomeres, the emphasis in this review will be
primarily on human telomeres. Single molecule ﬂuores-
cence energy transfer (FRET) studies of structure and
unfolding kinetics of the intramolecular human telomere
G-quadruplex revealed two stable folded conformations in
both K
+ and Na
+ buﬀers (92). Both folded conforma-
tions can be opened by addition of complementary
oligonucleotide, with temperature dependent studies
indicating that unfolding is entropically driven in
K
+ buﬀers (H=6.4kcalmol
 1 and S= 52.3
calmol
 1K
 1), while unfolding in Na
+ buﬀers exhibits
a more signiﬁcant enthalpic barrier (H=14.9kcalmol
 1
and S= 23.0kcalmol
 1K
 1). Single-molecule FRET
spectroscopy has also been used to probe the dynamics of
human telomeric DNA containing four guanine-tracts in
K
+ solution. Interconversion was detected between three
FRET values, interpreted in terms of an unfolded and two
folded G-quadruplex states, each of which was further
subdivided into long- and short-lived species (93). The
short-lived species were shown to determine the overall
dynamics, apparently because they bridge transitions
between the long-lived G-quadruplex states.
Single-repeat sequences
The earliest structural information of the human telomere
focusedonNMRstudiesofthesingle-repeatd(TTAGGGT)
human telomere sequence in K
+ cation solution (4). The
NMR data established that the single-repeat human
telomere sequence tetramerizes to form an all-parallel-
stranded G-quadruplex composed of three stacked
G-tetrads with all anti guanine glycosidic torsion angles.
Two-repeat sequences
The X-ray structure of d(TAGGGTTAGGGT) crystals
grown from K
+-containing solution deﬁned the architec-
ture of the G-quadruplex formed by the two-repeat
human telomere sequence (17). The structure contained
an unanticipated all-parallel-stranded G-quadruplex fol-
lowing bimolecular association of the two-repeat human
telomere sequences, with the TTA segments forming
double-chain-reversal (or propeller) loops (Figure 3a).
In addition, the end segments also participate in formation
of a T–A–T–A tetrad, through pairing of the major groove
edges of Watson–Crick A–T pairs (17).
NMR studies on the two-repeat human telomere
sequence d(TAGGGTTAGGGT) demonstrates intercon-
version between two dimeric G-quadruplex conformers
consisting of three stacked G-tetrads in K
+ solution (94).
One of these conformers adopts a symmetric all-parallel-
stranded G-quadruplex with double-chain-reversal loops
andallantiguanines(Figure3b),similartothatobservedin
the crystal structure (17). This conformer predominates for
an analog containing a speciﬁc dU (in bold) for T
substitution (designated U6)
50-T1AGGG5(dU)TAGG10GT-30
The other conformer adopts an asymmetric anti-parallel
G-quadruplex with edge-wise loops composed of six syn
guanines and six anti guanines (Figure 3c). This conformer
predominates for an analog (designated U1,
brU7) contain-
ing speciﬁc dU and d
brU (in bold) for T substitutions
50-(dU)1AGGG5T(d
brU)AGG10GT-30
NMR-based complementary-strand trap, concentration-
jump and temperature-jump methods have been used
to monitor the kinetics of interconversion and activ-
ation barriers between the parallel and anti-parallel
G-quadruplex conformers (94). The equilibrium shifts
towards the anti-parallel G-quadruplex (Figure 3c) at low
temperature and towards the parallel G-quadruplex
(Figure 3b) at high temperature for the U1,
brU7 sequence,
with the corresponding enthalpy being 18.5kcal mol
 1.
Furthermore, the anti-parallel G-quadruplex folds faster,
but unfolds slower than the parallel quadruplex at
temperatures below 408C.
A related conformational equilibrium has also been
observed between a pair of bimolecular G-quadruplexes
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Figure 3. (a) X-ray structure of the two-repeat human telomere
bimolecular G-quadruplex formed by the d(TAGGGTTAGGGT)
sequence for crystals grown from K
+ solution (coordinates deposition:
1K8P) (17). The bases are color coded as follows: guanine (blue),
adenine (green) and thymine (orange). All strands are parallel in this
bimolecular quadruplex and the loops are of the double-chain-reversal
or propeller type. NMR-based folding topologies of interconverting
(b) all parallel-stranded and (c) anti-parallel-stranded conformations of
the two-repeat human telomere bimolecular G-quadruplex formed by
the d(TAGGGTTAGGGT) sequence in K
+ solution (94).
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Tetrahymena sequence in Na
+-containing solution (95).
Three-repeat sequences
NMR-based studies have deﬁned the folding topology
(Figure 4a) and solution structure (Figure 4b) of the three-
repeat human telomere sequence d[G3(T2AG3)2T]
50-G1GGTT5AGGGT10TAGGG15T-30
in Na
+ solution (96). This sequence forms a unique
asymmetric bimolecular quadruplex, in which the core
composed of three stacked G-tetrads, involves all three
G-tracts from one strand and only the last G-tract of the
second strand. In this (3+1) G-quadruplex assembly,
there is one syn–syn–syn–anti and two anti–anti–anti–syn
G-tetrads, two edge-wise loops, three G-tracts oriented in
one direction and the fourth oriented in the opposite
direction (Figure 4a).
The (3+1) G-quadruplex topology adopted by the
three-repeat human telomere sequence establishes how a
segment containing three G-tracts can bind to the 30-end
G-tract of another segment. Such quadruplex formation
could occur within the 30-end overhang of human
telomeres or when the 30-end invades the adjacent
double-stranded segment of the telomere to form the
so-called t-loop (see schematic in Figure 4c) (97).
Earlier studies on four-repeat sequences
In 1993, the NMR-based folding topology (Figure 5a) and
solution structure (Figure 5b) of the four-repeat human
telomeric sequence d[AG3(T2AG3)3]
50-A1GGGT5TAGGG10TTAGG15GTTAG20GG-30
was solved in Na
+ cation solution (9). The intramolecular
fold contained three stacked G-tetrads connected by
successive edge-wise, diagonal and edge-wise TTA loops.
Each guanine-tract had both parallel and anti-parallel
aligned neighboring strands around the G-quadruplex,
with guanines adopting syn–syn–anti–anti glycosidic tor-
sion alignments around each G-tetrad. The grooves were
accessible for further recognition within this topology,
while the connecting loops restricted access to the
outward-directed faces of the terminal G-tetrads at both
ends. Finally, the 50- and 30-terminii project toward the
same ends of the G-quadruplex (Figure 5a).
The X-ray structure of d[AG3(T2AG3)3] crystals grown
from K
+ cation solution exhibited a completely diﬀerent
and unanticipated fold (Figure 5c) and structure
(Figure 5d) for the intramolecular G-quadruplex (17).
The G-quadruplex was composed of three stacked
G-tetrads, such that all strands are parallel, all guanines
adopt anti conformations and all three loops are of the
double-chain-reversal (or propeller) type. The double-
chain-reversal loops restrict access to three of the grooves,
while access is available to the outward-directed faces
of the terminal G-tetrads at both ends. Finally, the 50- and
30-terminii project toward opposite ends of the
G-quadruplex (Figure 5c), thereby facilitating potential
end-to-end alignments of successive G-quadruplexes.
These very diﬀerent conformers reported for the four-
repeat human telomeric sequence in Na
+-containing
aqueous solution (9) and in K
+-containing crystals (17)
appear to highlight the polymorphic character of
G-quadruplex scaﬀolds (93) as a function of medium
and/or monovalent cation type. Nevertheless, accumulat-
ing evidence, including biophysical measurements (98),
implied that the intramolecular parallel-stranded
G-quadruplex structure of the human telomere observed
in K
+-containing crystals, appears unlikely to be the
major form in K
+-containing aqueous solution. To this
end, three groups have recently systematically investigated
the solution structure(s) of four guanine-repeat human
telomeric sequences in K
+ cation solution, while keeping
in mind that the more crowded environment of the crystal
may more closely reﬂect the crowded situation in the cell
nucleus.
Morerecent studies onfour-repeat sequences
The imino proton NMR spectrum of d[AG3(T2AG3)3]i n
K
+ cation solution is indicative of multiple conformations
in equilibrium and hence this sequence context is not
readily amenable to structural characterization. Three
research groups (those of Hiroshi Sugiyama, Danzhou
Yang and our group) have taken somewhat diﬀerent
approaches to overcome this limitation and recently
contributed to determination of the solution structure(s)
of four-repeat human telomeres in K
+ solution. Our
group’s approach is outlined in detail below and these
results are placed in the context of independent contribu-
tions from the other two groups.
The imino proton NMR spectra corresponding to
distinct predominant conformers together with one or
more minor conformers were observed for the
G13
G15
G13
G15
G1
G3
G7
G9
(a) (b)
G9
G7 G15
G1
G3
G13
G15
(c) t-loop
D-loop
3'
5'
3'
5'
Figure 4. NMR-based (a) (3+1) folding topology and (b) solution
structure of the three-repeat human telomere bimolecular G-quadruplex
formed by the d[G3(T2AG3)2T] sequence in Na
+ solution (coordinates
deposition: 2AQY) (96). All three G-tracts from one strand and
the 30-terminal G-tract from the partner strand are used to form the
bimolecular G-quadruplex. (c) Schematic of hypothetical G-quadruplex
formation when the 30-end overhang (in red) invades the adjacent double-
stranded segment of the telomere to form the so-called t-loop (97).
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50-end (99), and for the d[TAG3(T2AG3)3TT] sequence,
where a T was added at the 50-end and a TT was added at
the 30-end (100), both in K
+ cation solution, with both
cases maintaining the sequence context of the TTAGG
human telomere repeat.
50-T1AGGG5TTAGG10GTTAGG15GTTAG20GG(TT)-30
The NMR-based folding topology was determined for
the predominant conformer of the d[TAG3(T2AG3)3]
sequence in K
+ cation solution (Figure 6a), and the
solution structure determined for an analog containing
terminal modiﬁcations (underlined) of this sequence,
namely d[TTG3(T2AG3)3A], with the latter yielding
exceptional NMR spectra reﬂecting a single conformer,
together with the same 2D spectral characteristics of the
unmodiﬁed sequence (99). Similarly, insertion of a single
8-bromoguanine at position G16 in the d[TAG3(T2AG3)3]
sequence to enforce a syn glycosidic bond at this position
also resulted in NMR spectra corresponding to a single
conformer with all the spectral characteristics of the
unmodiﬁed sequence (101). The solution structure has
been determined for the d[TAG3(T2AG3)3] G-quadruplex
(designated human telomere G-quadruplex form-1)
(Figure 6b) (101), whose (3+1) topology diﬀers from
folds reported previously in Na
+ solution (Figure 5a) (9)
and K
+-containing crystal (Figure 5c) (17). Instead, this
G-quadruplex contains three G-tracts oriented in one
direction and the fourth in the opposite direction, one
anti–syn–syn–syn and two syn–anti–anti–anti G-tetrads,
and a double-chain-reversal loop followed by two
edge-wise loops (99).
The same G-quadruplex folding topology (Figure 6a)
has been independently reported for the four-repeat
human telomere sequences in K
+-containing solution by
two other laboratories, one of which used NMR
(102,103), while the other used both CD (104) and
NMR (105). The NMR investigation by the former
group focused on the sequence d[AAAG3(T2AG3)3AA],
with the resulting (3+1) topology (102) stabilized by a
stacked A–A–A triple (103), associated with introduction
of terminal adenine modiﬁcations (underlined) at either
end of the sequence. The latter groups research avoided
terminal modiﬁcations and was based on judicious
positioning of between four and ﬁve 8-bromoguanine
substitutions, which enforce a syn guanine alignment at
the corresponding guanines in the sequence (104,105).
The NMR-based folding topology has also been
determined for the predominant conformer of the
d[TAG3(T2AG3)3TT] sequence in K
+ cation solution
(100). This sequence adopts the same (3+1) G-quadruplex
core topology adopted by the predominant conformer of
the d[TAG3(T2AG3)3]i nK
+ cation solution (99) outlined
in the previous paragraph, except that the ﬁrst two linkers
are of the edge-wise type and the last linker adopts a
double-chain-reversal loop (designated human telomere
G-quadruplex form-2) (Figure 6c). Insertion of a single
8-bromoguanine at position G15 in the sequence to
enforce a syn glycosidic bond at this position resulted in
NMR spectra corresponding to a single conformer with all
the spectral characteristics of the unmodiﬁed sequence
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Figure 5. NMR-based (a) folding topology and (b) solution structure of the four-repeat human telomere unimolecular G-quadruplex formed by the
d[AG3(T2AG3)3] sequence in Na
+ solution (coordinates deposition: 143D) (9). The loop types starting from the 50-end are edge-wise, diagonal and
edge-wise. Individual strands have both a parallel and anti-parallel neighbor, with the G-tetrads adopting syn–syn–anti–anti alignments. X-ray-based
(c) folding topology and (d) crystal structure of the four-repeat human telomere unimolecular G-quadruplex formed by the d[AG3(T2AG3)3] sequence
for crystals grown from K
+ solution (coordinates deposition: 1KF1) (17). All three loops are of the double-chain-reversal or propeller type, all
strands are parallel and all guanines adopt anti alignments.
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G-quadruplex form-2 is shown in Figure 6d (101). An
independent NMR-based study (106) has reached the
same conclusions reported above regarding the folding
topology (100) and solution structure (101) of form-2.
The demonstration of G-quadruplex forms 1
(Figure 6a) and 2 (Figure 6c) for the four-repeat human
telomere in K
+, together with the all-parallel-stranded,
propeller-groove-linked G-quadruplex observed in crys-
tals grown from K
+ solution (Figure 5c) (17), support the
view that multiple human telomeric G-quadruplex con-
formers can coexist in K
+-containing solution, a conclu-
sion reached from single molecule FRET studies of the
four-repeat human telomere sequence (92). Furthermore,
these studies establish that even small changes to ﬂanking
sequences perturb the equilibrium between diﬀerent
coexisting (3+1) G-quadruplex forms. More recent
research has attempted to monitor G-quadruplex forma-
tion by the four-repeat human telomere in K
+ solution
under polyethylene glycol-induced crowding conditions
(107) that perhaps mimic crystallization conditions.
(3+1)G-quadruplex fold
The (3+1) G-quadruplex scaﬀold is unique in that three
stands are oriented in one direction and the fourth
oriented in the opposite direction. Furthermore, two of
the three G-tetrads adopt anti–anti–anti–syn alignments
while the remaining G-tetrad adopts a syn–syn–syn–anti
alignment. This topology was ﬁrst reported in 1994 for the
four-repeat Tetrahymena telomere sequence, d(T2G4)4,i n
Na
+ solution (7) and observed a decade later for a four
guanine-repeat variant bcl-2 promoter in K
+ solution in
which two guanines were replaced by thymines (108)
(see bcl-2 sequence section).
The adaptation of the (3+1) core G-quadruplex by the
three-repeat human telomere dimeric G-quadruplex in
Na
+ solution (Figure 4a) (96), as well as by the four-
repeat human telomere G-quadruplexes form-1
(Figure 6a) and form-2 (Figure 6c) in K
+ solution,
established it to be a robust folding topology, thereby
highlighting its candidacy as an important platform for
structure-based drug design.
ONCOGENIC PROMOTER G-QUADRUPLEXES
Bioinformatics sequence analysis indicates that guanine-
rich tracts capable of G-quadruplex formation are
prevalent in the human genome (39–41). In addition,
it has recently been shown that promoter regions spanning
1kb upstream of transcription start sites of genes are
signiﬁcantly enriched in putative G-quadruplex-forming
motifs and that these putative promoter G-quadruplex-
forming regions strongly associate with nuclease hyper-
sensitivity sites (109). It has been suggested that such
promoter-based G-quadruplexes may be directly involved
in gene regulation at the level of transcription (110). This
has led to extensive investigations of the role of promoter-
mediated G-quadruplex formation in transcriptional
regulation of the oncogenic promoters of c-myc (111),
VEGF (112), HIF-1  (113), bcl-2 (114) and c-kit (115,116).
Since promoter regions are part of DNA duplexes,
they would be unwound during replication, prior to
G-quadruplex formation. Support for this concept has
emerged from single-molecule FRET studies on the c-kit
promoter (117). This process could be facilitated by
formation of single-stranded tracts during transcription
and further stabilized through addition of G-quadruplex-
stabilizing ligands (118).
Earlierstudies on c-mycsequence
Human c-myc is a transcription factor that is central to
regulation of cell growth, proliferation, diﬀerentiation and
apoptosis (119–121). The c-myc gene that encodes this
protein is tightly regulated in normal cells and its aberrant
overexpression is associated with the progression of many
cancers (122). c-myc can be deregulated as a result of
translocation, mutation and/or ampliﬁcation. An impor-
tant element in the c-myc promoter region, termed the
nuclease hypersensitivity element IIII (NHE IIII), controls
up to 90% of total c-myc transcription (123). The 27-nt
purine-rich strand of this element, which contains six
guanine-tracts (underlined)
50-T1GGGG5AGGGT10GGGGA15GGGTG20GGGAA25GG-30
has the capacity for forming alternate G-quadruplex folds
depending on which tracts participate in scaﬀold
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Figure 6. NMR-based (a) folding topology and (b) solution structure of
the four-repeat human telomere unimolecular G-quadruplex formed by
the d[TAG3(T2AG3)3] sequence (form-1) in K
+ solution (coordinates
deposition: 2JSM, 2JSK) (101). The loop types starting from the 50-end
are double-chain-reversal, edge-wise and edge-wise. Two other groups
have independently investigated the same system and come to similar
conclusions (102–105). NMR-based (c) folding topology and
(d) solution structure of the four-repeat human telomere unimolecular
G-quadruplex formed by the d[TAG3(T2AG3)3TT] sequence (form-2) in
K
+ solution (coordinates deposition: 2JSL, 2JSQ) (101). The loop
types starting from the 50-end are edge-wise, edge-wise and double-
chain-reversal. One other group has independently investigated the
same system and come to similar conclusions (106).
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within the 27-nt c-myc segment that destabilize G-
quadruplex formation, result in increased c-myc transcrip-
tion, while ligands like the porphyrin TMPyP4 that
stabilize G-quadruplex formation, result in decreased c-
myc transcription (111).
The imino proton NMR spectrum of the 27-nt c-myc
NHE IIII segment containing six guanine-tracts exhibited
characteristics of multiple G-quadruplex folds in equili-
brium, including a broad envelope characteristic of
aggregated species, precluding structural characteriza-
tion. Therefore, systematic NMR studies have been
restricted to four and ﬁve guanine-tract sequences as
part of an eﬀort towards understanding the underlying
principles contributing to c-myc G-quadruplex
formation.
Initial eﬀorts have focused on G-quadruplexes that can
be generated through involvement of four of the six
guanine-tracts associated with the 27-mer c-myc NHE
IIII element. Over 50 sequence variants were checked
prior to the identiﬁcation of two that gave imino proton
spectral quality reﬂective of distinct single conformers
that justiﬁed further structural characterization (126).
One of these involved the second, third, fourth and ﬁfth
guanine-tracts (designated c-myc-2345) as reﬂected in the
sequence
TG5AGGGT10GGGGA15GGGTG20GGGAA25
while the other involved the ﬁrst, second, fourth and ﬁfth
guanine-tracts (designated variant c-myc-1245), with the
guanines of the third tract replaced by thymines (in bold,
below), as reﬂected in the sequence
T1GGGG5AGGGT10TTTTA15GGGTG20GGGA
The resulting NMR-based intramolecular G-quadruplex
folding topologies in K
+ solution for both c-myc-2345
and thymine for guanine-containing variant c-myc-1245
sequences contain a core of three stacked G-tetrads
formed by four parallel G-tracts with all anti guanines
and three double–chain-reversal loops bridging G-tetrad
layers (126). The c-myc-2345 fold is shown in Figure 7a,
while that for variant c-myc-1245 is shown in Figure 7b.
These studies establish that single-residue (A or T) double-
chain-reversal loops can bridge three G-tetrad layers.
Indeed, systematic studies of DNA quadruplexes with
diﬀerent arrangements of short and long loops conﬁrm
that single-residue loops favor parallel-stranded topolo-
gies (127). Of the two G-quadruplex folds, c-myc-2345,
which has a two-residue central loop (Figure 7a), is more
stable by 158 than variant c-myc-1245, which has a six-
residue central loop (Figure 7b), in K
+ solution. This is
also reﬂected in the imino proton exchange lifetimes of the
central G-tetrads, which are longer for the c-myc-2345
compared to variant c-myc-1245, suggesting slower
unfolding kinetics for the former G-quadruplex (126).
An NMR-based solution structure has been reported
for a variant c-myc-2345 sequence in which guanines G14
and G23 have been replaced by thymines (in bold, below)
TG5AGGGT10GGGTA15GGGTG20GGTAA25
The solution structure of this variant c-myc-2345
(Figure 7c) (128) adopts the topology (Figure 7a) shown
previously for unmodiﬁed c-myc-2345 (126).
The NMR-based G-quadruplex topologies for myc-2345
(Figure 7a) and variant myc-1245 (Figure 7b) (126), as well
as the related study of the solution structure of the variant
c-myc-2345 (Figure 7c) (128) G-quadruplexes correct
earlier conclusions regarding proposed c-myc folding
topologies based solely on interpretation of footprinting
data (111), in an otherwise highly cited contribution.
More recent studies on c-myc sequence
The variant c-myc-1245 (126) and c-myc-2345 (128)
sequences replace guanines by thymines within G-rich
tracts. Thymine, unlike inosine, has nothing in common
with guanine, and thymine for guanine substitutions
represent a signiﬁcant perturbation of the wild-type
c-myc sequence. Therefore, structural studies were next
extended to the c-myc sequence containing ﬁve of the six
guanine-tracts associated with the 27-mer c-myc NHE IIII
element, while avoiding any thymine for guanine substitu-
tions. This sequence (designated c-myc-23456)
50-TG5AGGGT10GGGGA15GGGTG20GGGAA25GG-30
is composed of the second, third, fourth, ﬁfth and sixth
guanine-tracts. The NMR-based folding topology
(Figure 8a) and solution structure (Figure 8b) of the
c-myc-23456 G-quadruplex in K
+ solution is composed of
three stacked guanine tetrads formed by four parallel
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Figure 7. NMR-based folding topology of unimolecular
G-quadruplexes formed by (a) myc-2345 and (b) thymine for guanine-
containing variant myc-1245 sequences in K
+ solution (126). (c) NMR-
based solution structure of the thymine for guanine-containing variant
myc-2345 promoter unimolecular G-quadruplex in K
+ solution
(coordinates deposition: 1XAV) (128).
7436 Nucleic Acids Research, 2007, Vol. 35, No. 22guanine-tracts with all anti guanines and a snap-back
30-end syn guanine (129). The guanines involved in
G-tetrad formation are highlighted in bold below
50-TG5AGGGT10GGGGA15GGGTG20GGGAA25GG-30
and involve guanines from each of the ﬁve tracts.
This snap-back conﬁguration is facilitated by a stable
diagonal loop, which contains a G–(A-G) triad, which
stacks on and caps the G-tetrad core at one end of the
G-quadruplex. The 50- and 30-ends of the sequences are
at opposite ends of the snap-back c-myc-23456
G-quadruplex (Figure 8a) (129), as they are for the
c-myc-2345 (Figure 7a) and variant c-myc-1245
(Figure 7b) G-quadruplexes (126).
c-kit sequences
The proto-oncogenic c-kit promoter encodes for a tyrosine
kinase receptor, thereby regulating signal transduction
cascades that control cell growth and proliferation (130).
Oncogenic cellular transformations in c-kit are associated
with mutations in structurally important regions, with
human gastrointestinal stromal tumors (GIST) associated
with mutations around the two main autophosphorylation
sites in the juxtamembrane region (131), while myeloid
leukemias and human germ cell tumors are associated
with kinase domain mutants (132). The drug Gleevec
(imatinib) is an eﬀective in vitro and in vivo inhibitor of c-
kit kinase activity and is widely used clinically against
GIST (133). Like other small molecule drugs targeted
against kinases, new patterns of resistance mutations
within the active site, result in diminished binding and
clinical eﬀectiveness of the drug (134).
Selective gene regulation at the transcription level
provides an alternate approach to c-kit inhibition. This
can be achieved by induction of G-quadruplex structures
within G-rich tracts of the c-kit promoter and their
potential stabilization by bound ligands. Recently, imino
proton NMR spectral studies established that the c-kit1
22-mer sequence
50-A1GGGA5GGGCG10CTGGG15AGGAG20GG-30
positioned between  87 and  109nt upstream of the
transcription start site of the human c-kit gene, forms a
single G-quadruplex scaﬀold in K
+ solution (115).
Expectations that this sequence, which contains four
GGG tracts (underlined, above), forms a conventional
G-quadruplex, appeared unlikely when it was found that
mutations within the linker segments were detrimental to
G-quadruplex formation (115). It should be mentioned
that a second highly conserved guanine-rich sequence has
been recently identiﬁed in the c-kit gene, at a site critical
for core promoter activity (116).
The NMR-based solution structure has been deter-
mined for the 22-mer c-kit1 sequence in K
+ cation
solution (135). The c-kit1 sequence, which exhibits
an exceptionally well-resolved NMR spectrum (115),
adopts a G-quadruplex topology (Figure 8c) and solution
structure (Figure 8d) composed of three stacked G-tetrads
and four connecting loops. The guanines involved in
G-tetrad formation (in bold, below) include isolated
guanine G10, but excludes G20 of the last G-tract.
50-A1GGGA5GGGCG10CTGGG15AGGAG20GG-30
Two single-residue linkers (A5 and C9) form two double-
chain-reversal loops that bridge three G-tetrad layers, the
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Figure 8. NMR-based (a) folding topology and (b) solution structure of the unimolecular G-quadruplex formed by the myc-23456 sequence in K
+
solution (coordinates deposition: 2A5P) (129). NMR-based (c) folding topology and (d) solution structure of the unimolecular G-quadruplex formed
by the c-kit1 sequence in K
+ solution (coordinates deposition: 2O3M) (135).
Nucleic Acids Research, 2007, Vol. 35, No. 22 7437two-residue linker connects two adjacent corners (G10
and G13), while the ﬁve-residue linker allows the terminal
G21–G22 step to be inserted back into the G-quadruplex
core. The loops are stabilized through formation of a
Watson–Crick A–T pair that stacks over the top of the
G-quadruplex and two non-canonical G–A pairs that
stack over the bottom of the G-quadruplex.
This structure establishes a new folding principle that an
isolated guanine (G10 in the present case) within a non-
G-tract segment can participate in the formation of the
structured G-quadruplex core (135). This result raises an
element of caution regarding the use of programs that
predict G-quadruplex folding topologies from sequence
data,wheretheyrelysolelyontheparticipationofguanines
within G-tracts. Another notable feature is associated with
formation of a snap-back parallel-stranded G-quadruplex
core, where the last two guanines insert back into the core
to complete adjacent G-tetrad alignments (Figure 8c). The
50- and 30-ends of the sequences are at opposite ends of the
snap-back c-kit1 G-quadruplex, thereby allowing contin-
uation of the DNA sequence in both directions without
signiﬁcant steric hindrance.
Both the c-myc 23456 (Figure 8a) (129) and c-kit1
(Figure 8c) (135) scaﬀolds contain distinct pronounced
clefts, with their unique surface topologies making them
attractive site-selective targets for drugs.
bcl-2 sequence
The bcl-2 gene mediates the t(14;18) chromosomal
translocation associated with the onset of lymphomas
(136,137). The bcl-2 gene is overexpressed in several
human cancers, with the gene product functioning as an
apoptosis inhibitor, thereby impacting adversely on the
therapeutic action of cancer treatment regimes in the clinic
(138). Thus, both the bcl-2 gene and its gene product
constitute rational targets for anti-cancer therapy.
Transcriptional initiation of bcl-2 is controlled by a
major promoter P1, containing a guanine-rich strand
upstream of the initiation site and proximal to a nuclease
hypersensitivity region (114). This bcl-2 promoter region
contains six guanine-tracts containing three or more
contiguous guanines (underlined)
50-GGGGCG1GGCG5CGGGA10GGAAG15GGGGC20GGGAG25
CGGGG-30
with non-denaturing gel, footprinting and cd data inter-
preted in terms of a mixture of at least three G-quadruplex
conformers in K
+ solution. The second to ﬁfth
G-tracts (designated bcl-2 2345) forms the most stable
G-quadruplex (114), and an attempt has been made
to structurally investigate this sequence composed of the
four central guanine-tracts. The NMR studies were
undertaken on a variant in which guanines G15 and
G16 were replaced by thymines (in bold, below) (108).
50-G1GGCG5CGGGA10GGAAT15TGGGC20GGG-30
The thymine for guanine-containing variant of the bcl-2
2345 adopts a (3+1) G-quadruplex topology (108)
(Figure 9a) and solution structure (139) (Figure 9b).
The same (3+1) G-quadruplex scaﬀold was ﬁrst
reported over a decade ago for the four-repeat
Tetrahymena telomere sequence, d(T2G4)4,
50-T1TGGG5GTTGG10GGTTG15GGGTT20GGGG-30
in Na
+ solution, with its unanticipated double-chain-
reversal loop-containing folding topology (Figure 9c) and
solution structure (Figure 9d) (7), considered to be an
anomaly at that time.
Replacement of single guanines by inosines, where the
exocyclic amino groups are replaced by protons,
have been used previously in NMR-based studies of
G-quadruplex formation in eﬀorts to improve spectral
quality (96). By contrast, replacement of two guanines by
thymines in variant bcl-2 2345 constitutes a much more
serious perturbation, especially for an internal guanine-
tract, preventing these two guanines from potential
participation in G-tetrad formation. Thus, opportunities
exist for structurally investigating unperturbed bcl-2
oncogenic promoter sequences, perhaps involving ﬁve of
the six guanine-tracts, as was accomplished previously for
c-myc-23456 (129).
VEGF and HIF-1asequences
Vascular endothelial growth factor (VEGF) stimulates the
formation of new blood vessels, providing oxygen and
nutrients to primary tumor sites, thereby facilitating the
proliferation of cancer cells. VEGF-mediated tumor
angiogenesis, has stimulated interest in the VEGF gene
and its potential as a target for cancer therapy (140).
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Figure 9. NMR-based (a) (3+1) G-quadruplex folding topology
and (b) solution structure of the thymine for guanine-containing
variant bcl-2 2345 promoter unimolecular G-quadruplex in K
+ solution
(coordinates deposition: 2F8U) (139). NMR-based (c) (3+1) G-
quadruplex topology and (d) solution structure adopted by the
four-repeat Tetrahymena telomere unimolecular G-quadruplex formed
by the d[(T2G4)4] sequence in Na
+ solution (coordinates deposition:
186D) (7).
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regulated at the transcription level, with the VEGF
promoter containing a purine-rich strand composed of
ﬁve guanine-tracts of at least three guanines each
(underlined)
50-G1GGGC5GGGCC10GGGGG15CGGGG20TCCCG25
GCGGG30G-30
that also serves as binding sites for Sp1 and Egr-1
transcription factors. The guanine-rich VEGF sequence
forms G-quadruplex structures in monovalent cation
solution (as monitored by cd and footprinting measure-
ments), which are stabilized by G-quadruplex-interacting
agents TMPyP4 and telomestatin (112). In addition, a
DNase1 and S1 nuclease hypersensitivity site was identi-
ﬁed to the 30-side of the G-quadruplex forming region, but
not for mutant sequences that inhibit quadruplex forma-
tion. Finally, the cd spectrum of the guanine-rich VEGF
sequence in K
+ is consistent with formation of a parallel-
stranded G-quadruplex. Overall, the results are suggestive
of the importance of structural transitions in enhancing
open promoter complex formation, thereby facilitating
transcriptional regulation (112).
Hypoxia inducible factor-1a (HIF-1a) is activated in
many common human tumors and is associated with local
invasion and metastasis (141). The HIF-1  promoter
contains ﬁve guanine-rich tracts of at least three guanines
each (underlined)
50-G1GGCG5CGCGG10GGAGG15GGAGA20GGGGG25CGGG-30
capable of all-parallel-stranded G-quadruplex formation
in K
+ solution, as indicated by chemical probing, cd and
DNA polymerase arrest assays (113). Considerable
eﬀort has gone towards targeting HIF-1a in cancer
therapy (142).
To date, no systematic structural investigations have
been undertaken to determine the G-quadruplex struc-
tures adopted by the guanine-rich tracts of either the
VEGF or HIF-1  promoters.
TRIPLET REPEAT DISEASE G-QUADRUPLEXES
A series of nucleotide or repeat expansion disorders
caused by the dynamic intergenerational expansion of
triple repeat d(CGG)n–d(CCG)n, d(CAG)n–d(CTG)n and
d(GAA)n–d(TTC)n sequences are associated with neuro-
logical, neuromuscular and neurodegenerative disorders
(143,144). These diseases exhibit genetic anticipation,
whereby the symptoms and penetrance are manifested
in subsequent generations at a decreased age of onset and
increased severity. The expandable repeats are found in
diverse settings ranging from coding segments, to 50- and
30-UTRs, promoter regions and introns. It is likely that
the pathogenesis of these debilitating diseases, and their
disruption of cellular replication, repair and recombina-
tion machineries, reﬂects unusual DNA conformations
generated for long repeats, for which several secondary
structural models have been proposed in the literature
(145–149). These guanine-containing repeats within
complementary repetitive strands of the duplex can form
slip-out hairpin-like folds (150), which in turn could
form higher order architectures, including quadruplex
formation following bimolecular association. One of
these repeat expansion models proposes that the higher
order structures stall the replication fork, giving time
for addition of extra repeats, prior to replication fork
restart (151).
Though the early emphasis on triplet expansion diseases
was focused on the DNA template, more recent analysis
has brought RNA repeats to the forefront, with the
emphasis on gain-of-function contributions at the RNA
level (152). Thus, structural studies need to be undertaken
on both triplet repeat-containing DNAs and RNAs.
CGG triplet repeats
There has been considerable interest in the molecular basis
for expansion of d(CGG)n–d(CCG)n tracts in genomic
DNA that results in the onset of the FXMR syndrome
(153,154), the single most common inherited cause of
mental retardation (155). The d(CGG)n triplet repeat (can
be designated CGG, GGC or GCG repeat depending on
the phase of the readout) is observed within the ﬁrst exon
of the FMR-1 gene with n < 30nt in normal individuals.
This number increases up to  200nt in premutation
carriers and further expands up to 2000nt in individuals
aﬄicted with fragile X syndrome. The genetic instability
associated with the expansion of d(CGG)n repeats to the
diseased state is facilitated by hypermethylation of
cytosine residues (156) and results in suppression of
FMR-1 gene transcription (154) and delay in replication
in patients with the FMR-1 syndrome (157). It was
initially shown that the fragile X syndrome d(CGG)n
repeat forms a stable G-quadruplex in the presence of
monovalent cations when n=7, and also when n=5, for
its methylated cytosine counterpart (158). In addition,
d(CGG)n repeats form structures that block DNA
synthesis in vitro (159), with the block overcome by the
Werner syndrome (WRN) helicase (160). Interestingly, the
cationic porphyrin TMPyP4 (161) and the hnRNP-related
protein CBF-A (162,163), both destabilize quadruplex
formation, in contrast to their structural stabilization of
the human telomere G-quadruplex.
Very high-quality NMR spectra were observed for
d(GCGGT3GCGG), a sequence that embeds CGG and
GCG steps, in Na
+ solution, thereby deﬁning a distinct
folding topology (Figure 10a) and solution structure
(Figure 10b) (164).
50-G1CGGT5TTGCG10G-30
The sequence forms a bimolecular quadruplex containing
G–C–G–C tetrads (Figure 10c) ﬂanked by G–G–G–G
tetrads in solution. The loops adopt edge-wise conforma-
tions and are aligned at opposite ends of the bimolecular
quadruplex, while the strands directionalities alternate
around the G-quadruplex and the G-tetrads adopt
anti–syn–anti–syn alignments (Figure 10a). These studies
establish the pairing alignments that can be potentially
utilized by sequences containing the fragile X syndrome
d(CGG)n triplet repeat to form quadruplex structures.
Such quadruplex structures, stabilized by a mixture of
Nucleic Acids Research, 2007, Vol. 35, No. 22 7439G–C–G–C and G–G–G–G tetrads [see also, (165), for an
alternate, but not structurally characterized quadruplex
model], could serve as potential blockage sites for the
progress of replication forks and account for the blockage
at the fragile X locus observed experimentally (157).
GAA triplet repeats
The d(GAA)n-repeat is of considerable biological interest
since expansion of d(GAA)n–d(TTC)n triplet repeats
located within the ﬁrst intron of the frataxin gene
contributes to Friedrich’s ataxia, an autosomal recessive
neurodegenerative disease (166). The non-G–C rich nature
of the sequence, together with the intronic localization and
the requirement of both alleles, makes Friedrich’s ataxia
unique amongst the triplet-repeat disease sequences.
Expression of the d(GAA)n triplet repeat leads to reduced
levels of frataxin mRNA transcripts, and it has been
shown to reﬂect impediment in transcription elongation,
in a length and supercoil dependent manner (167). This
impediment could reﬂect formation of a stable nucleic acid
architecture (168), and several models have been proposed
ranging from triplexes (169) to parallel-stranded duplexes
(170). The parallel-stranded duplex model for d(GAA)n
triplet repeats is intriguing, since further bimolecular
pairing could result in quadruplex formation.
NOVEL QUADRUPLEX FOLDS AND TETRAD
PAIRING ALIGNMENTS
G-quadruplexes can contain pairing alignments beyond
the G-tetrad and considerable eﬀort has gone into deﬁning
these alignments. These include other homo- and mixed-
tetrad pairing alignments, triads, pentads, hexads and
heptads. Triads and triples are generally observed within
edge-wise and diagonal loop regions, where they stack on
terminal G-tetrads. By contrast, mixed tetrads, pentads
and hexads are observed at both the ends and within
G-quadruplexes.
Double-chain-reversal loops
Early structural studies identiﬁed edge-wise (9,15), and
diagonal (8,10) loops that bridged anti-parallel-aligned
columns around the G-quadruplex. An unanticipated
development was the identiﬁcation of double-chain-rever-
sal loops that bridged adjacent parallel-aligned columns
within the four-repeat Tetrahymena G-quadruplex (7).
In this case, two thymine residues span three stacked
G-tetrad planes. Next it was demonstrated that single
residue double-chain-reversal loops can span two
G-tetrad planes in an all parallel-stranded G-quadruplex
(16). The importance of double-chain-reversal loops
emerged center-stage following the structure determina-
tion of the four-repeat human telomere from crystals
grown in K
+ solution (17), where all three TTA loops
were of the double-chain-reversal (or hairpin) type and
each spanned three stacked G-tetrad planes (Figure 5c).
The next discovery was that single-residue double-chain-
reversal loops could span both two (16) and three (126)
stacked G-tetrads. The latter result was most unexpected
but was conﬁrmed in subsequent studies on additional
G-quadruplex folds (128,129,171,172).
Mixed tetrads
The standard view of G-quadruplex formation involves
a scaﬀold stabilized by stacked G–G–G–G tetrads. Never-
theless, mixed tetrads can also stabilize G-quadruplex
formation and these include major groove-
aligned G–C–G–C tetrads of the direct (Figure 10c)
(14,164,173,174) and slipped (Figure 10d) (26) type and
major groove-aligned A–T–A–T tetrads of the direct (17)
and slipped (173) type. Minor groove-aligned mixed
G–G–G–G and A–T–A–T tetrads have also been structu-
rally characterized, but the bases deviate signiﬁcantly from
the tetrad plane (175,176).
A–A–A–A tetrads
NMR studies on d(AGGGT) in K
+ solution
are consistent with formation of a parallel-stranded
G-quadruplex (177). Somewhat unexpectedly, nuclear
Overhauser enhancement (NOE) cross peaks were
observed between the adenine amino protons and the
non-exchangeable H8 and H2 protons. This has lead to
the proposal of A–A–A–A tetrad formation, with rapid
interconversion between N
6H   N
7 and N
6H   N
3
hydrogen-bonding alignments. Furthermore, the terminal
adenine residues appear to adopt syn glycosidic torsion
(b)
G1
G4
G8
G11
G8
G10
G3
G8
G4
G10
G4
C2
G1 G11
G3
C9
C9
G11
C2
G1
(a)
(c)
G
G
C
C
(d)
C
G
G
C
Figure 10. NMR-based (a) folding topology and (b) solution structure
of the bimolecular G-quadruplex formed by the d(GCGGT3GCGG)
sequence in Na
+ solution (coordinates deposition: 1A6M) (164).
Schematics illustrating mixed tetrad pairing alignments observed for
(c) direct and (d) slipped G–C–G–C tetrads, associated with pairing
along the major groove edges. A monovalent cation (gray ball) most
likely bridges the acceptor atoms along the major groove edges of
opposing guanines in the slipped G–C–G–C tetrad.
7440 Nucleic Acids Research, 2007, Vol. 35, No. 22angles based on the strong H8 to H10 NOEs observed
at short mixing times, suggestive of an A(syn)–
A(syn)–A(syn)–A(syn) alignment (177). A more deﬁnitive
approach would have been to use
15N isotopic label-
ing to directly monitor scalar coupling to deﬁne hydrogen-
bonding alignments (178,179); (174), thereby validating
the proposed A–A–A–A tetrad formation. The NMR-
based conclusions contrast with crystallographic studies
of RNA sequences (discussed in more detail in topo-
logies and tetrad alignments section), where A–A–A–A
tetrads have been deﬁnitively identiﬁed, but shown
to adopt A(anti)–A(anti)–A(anti)–A(anti) alignments
(180,181).
Triads
The concept of an anti-parallel DNA duplex stabilized
by base triads was proposed more than a decade ago (19).
A base triad involves alignment of three bases in a plane,
where a base from one strand interacts through hydrogen
bonding with two adjacent co-planar bases from the
partner strand. The coplanar-aligned adjacent bases
essentially form a platform, a feature identiﬁed initially
in RNA (182). A triad diﬀers from a triple, where the three
bases come from three distinct strands. There are now
several examples of base triads stacked over the terminal
G-tetrads of G-quadruplexes. These include A–(T-A)
(Figure 11a) (101,183), G–(C-A) (Figure 11b) (20),
T–(A-A) (184), T–(A-T) (101), G–(A-G) (129), and
G–(T-T) (185) triads, where in each case, the co-planar
adjacent bases that constitute the platform, are indicated
in brackets.
Pentads andhexads
NMR-based investigations of G-quadruplexes have also
identiﬁed formation of A–(G–G–G–G) pentads
(Figure 11c) (18,171), A–(G–G–G–G)–A hexads
(Figure 11d) (16) and heptads (186). Such alignments
essentially are composed of G–(A-G) triads, where one or
more A residue(s) align(s) along one or more minor
groove edge(s) of a G-tetrad.
Effectof guanine substitutions onG-quadruplex formation
A systematic and penetrating study has reported on the
impact of guanine modiﬁcations on formation of parallel
four-stranded G-quadruplexes (187). These authors mea-
sured G-quadruplex association and dissociation kinetics
to estimate the energetic penalty associated with single-site
modiﬁcations of 12 diﬀerent substitutions. Modiﬁcations
involving the hydrogen-bonding positions on the guanine
ring (O
6,N
1,N
2 and N
7) were detrimental to
G-quadruplex stability as reﬂected in decreased associa-
tion rate constants and reduced quadruplex lifetimes.
The most deleterious eﬀects were observed for central
guanine substitutions, suggestive of an important role for
this position in the nucleation process. By contrast,
modiﬁcations that perturb neither the central carbonyl
group alignment nor the cyclic hydrogen-bonding pattern
are tolerated, as are other planar bicyclic ring systems that
retain such constraints. Thus, substitution of guanine by
either 8-bromoguanine or 6-methyl-isoxanthopterin accel-
erates quadruplex formation, especially when substituted
at the 50-end of the G-tract. It is conceivable that the
bromo and methyl groups in these substitutions favor
hydrophobic collapse during the process of strand
association. These modiﬁcations also favor a syn glycosi-
dic torsion angle, which correlates with the observation
of syn glycosidic torsion angles at the 50-guanine positions
in (3+1) G-quadruplex scaﬀolds (7,101). Finally,
non-guanine tetrads are destabilizing when positioned
internally within a G-quadruplex, but can be accommo-
dated when positioned over terminal G-tetrads due to
stabilizing stacking interactions (187). A systematic study
has also been undertaken on the eﬀect of G-tract length
on the topology and stability of intramolecular
G-quadruplexes (188).
STACKED AND INTERLOCKED G-QUADRUPLEXES
Two G-quadruplexes can interact through end-to-end
stacking (16) or alternately through an interlocked
conﬁguration (18,171), where a guanine from one
monomer completes the G-tetrad through interaction
with three guanines from the other monomer.
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Figure 11. Schematics illustrating base triad pairing alignments for
(a) A–(T-A) (183), (b) G–(C-A) (20) triads. Schematics illustrating
(c) A–(G–G–G–G) pentad (18,171) and (d) A–(G–G–G–G)–A hexad
(16) alignments. NMR-based (e) folding topology and (f) solution
structure of end-to-end stacked tetramolecular G-quadruplexes formed
by four d(GGAGGAG) strands in 150mM Na
+ solution (coordinates
deposition: 1EEG) (16).
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those of the interlocked type, result in very stable
topologies, and can involve the participation of junctional
G–C–G–C tetrads (Figure 10c) (174), A–(G–G–G–G)
pentads (Figure 11c) (18) and A–(G–G–G–G)–A hexads
(Figure 11d) (16).
End-to-end stacked G-quadruplexes
Previous NMR-based studies had demonstrated that the
d(GGAGGAT) sequence formed a two-stranded arrow-
head motif-aligned solely through non-canonical pair
formation under low (10mM) Na
+ counterion conditions
(189). Further NMR-based studies of this sequence and
related d(GGAGGAG) indicated a pronounced confor-
mational change on proceeding to moderate (150mM)
Na
+ counterion conditions (16). Structural characteriza-
tion of the moderate salt conformer demonstrated
formation of end-to-end stacked G-quadruplexes invol-
ving four strands with a unique folding topology
(Figure 11e) and solution structure (Figure 11f) for the
d(GGAGGAG) sequence in 150mM Na
+ solution (16).
Each G-quadruplex monomer, formed by alignment of
two d(GGAGGAG) strands, is composed of a junctional
A–(G–G–G–G)–A hexad (Figure 11d), a G–G–G–G
tetrad and an A–A non-canonical pair. The A3 residue,
involved in double-chain-reversal loop formation, also
participates in A–(G–G–G–G)–A hexad formation.
The end-to-end stacking of G-quadruplex monomers is
mediated through stacking of their junctional A–(G–G–
G–G)–A hexads (Figure 11e). A combination of Brownian
dynamics and molecular dynamics simulations identiﬁed
several stable monovalent cation-binding sites within the
end-to-end stacked G-quadruplexes scaﬀold (16).
V-shaped scaffold mediates interlocked G-quadruplex
formation
The guanine-rich d(G3AG2T3G3AT) sequence
50-G1GGAG5GTTTG10GGAT-30
contains one GG and two GGG segments and therefore
was not expected to form a monomeric intramolecularly
folded G-quadruplex. Despite this limitation of lacking
four guanine-tracts, the sequence gave exceptional
NMR spectra associated with a single conformation in
Na
+ solution (18). The stoichiometry of two, coupled the
number of resonances, established that d(G3AG2T3G3AT)
folds by interaction between symmetry-related
G-quadruplexes. A uniformly
13C,
15N-labeled sample
was prepared to facilitate resonance assignments and
identify hydrogen-bonding alignments (178,179); (174).
NMR-based NOE and hydrogen-bonding constraints
deﬁned the folding topology (Figure 12a) and solution
structure (Figure 12b) associated with a pair of
interacting G-quadruplexes (18). Each symmetry-related
G-quadruplex monomer undergoes three sharp turns, with
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Figure 12. NMR-based (a) folding topology and (b) solution structure of the V-shaped interlocked bimolecular G-quadruplex formed by
the d(G3AG2T3G3AT) sequence in Na
+ solution (coordinates deposition: 1JJP) (18). NMR-based (c) folding topology and (d) solution structure of
interlocked bimolecular G-quadruplex formed by the d(G4TG3AG2AG3T) 93del sequence in K
+ solution (coordinates deposition: 1Y8D) (171).
7442 Nucleic Acids Research, 2007, Vol. 35, No. 22all purines involved in pairing alignments. The ﬁrst turn is
of the double-chain-reversal type, the second turn is of the
edge-wise type and the last involves a new alignment, the
V-shaped turn (Figure 2d). Each monomer contains two
stacked G(anti)–G(anti)–G(anti)–G(syn) tetrads, one of
which forms a A–(G–G–G–G) pentad. There is a break in
one of the four G-G columns that link adjacent G-tetrads
within each monomer, resulting in a V-shaped scaﬀold.
The A–(G–G–G–G) pentad from each monomer mutually
stack on each other, with each pentad containing four
bases from one monomer and a syn G1 from the partner
monomer, thereby resulting in interlocked G-quadruplex
formation (18).
TargetingHIV-1integraseusinginterlockedG-quadruplexes
HIV-1 integrase catalyzes the integration of proviral DNA
into the host-cell genome, a reaction critical for eﬃcient
viral replication. NMR-based studies have solved the
solution structure of an in vitro selected guanine-repeat-
containing 93del DNA sequence
50-G1GGGT5GGGAG10GAGGG15T-30
a potent nanomolar inhibitor of both processing and
strand transfer functions of HIV-1 integrase (190).
This sequence forms an unusually stable interlocked
G-quadruplex architecture in K
+ solution with a fold
shown schematically in Figure 12c and solution structure
shown in Figure 12d (171). Within each monomer subunit,
one A–(G–G–G–G) pentad is sandwiched between two
G–G–G–G tetrads, all G-stretches are parallel, are linked
by three double-chain-reversal loops, and all guanines
are anti, except for G1, which is syn. Interlocked
G-quadruplexes formation is achieved through mutual
pairing of G1 of one monomer, with three other guanines
of the other monomer, to complete junctional G-tetrad
formation.
The interlocked G-quadruplexes scaﬀold with its
distinct surface architecture could be shape-speciﬁcally
targeted by ligands, or in turn serve as a ligand that targets
interfacial channels on multimeric proteins. Indeed,
molecular docking approaches suggest that the 93del
interlocked DNA G-quadruplex could potentially be
positioned within a basic canyon formed between subunits
of the tetrameric HIV-1 integrase (171).
Snap-back G-quadruplexes
The snap-back parallel-stranded G-tetrad core scaﬀolds
have been observed for both the c-myc-23456 (Figure 8a)
(129) and the c-kit1 (Figure 8c) (135) G-quadruplexes. In
both cases, there is an interruption of the G-tetrad core,
with base-pairing alignments in the last connecting
loop important in stabilizing the snap-back scaﬀold.
The c-myc-23456 (Figure 8a) and c-kit1 (Figure 8c)
G-quadruplexes diﬀer in that the former involves insertion
of a single syn guanine (129), while the latter involves
insertion of two anti guanines (135). The snap-back
feature allows for continuation of the DNA sequence in
both directions without signiﬁcant steric hindrance.
RNA QUADRUPLEXES
The majority of attention has focused on DNA quad-
ruplexes, their diversity of scaﬀolds and their potential
role in biology. By contrast, RNA quadruplexes have
received less attention, despite implications of their
involvement at sites of RNA packaging (191), endonu-
cleolytic cleavage activity (192), translational control (193)
and mRNA turnover (73).
Topologies and tetradalignments
RNA quadruplex formation was initially established from
NMR studies on r(UGGGGU) (194) and subsequently by
a 0.61A ˚ crystal structure of the same sequence for crystals
grown in Sr
2+-containing solution (195). This sequence
forms a parallel four-stranded RNA quadruplex with all
anti guanines in both solution and the crystalline state,
with Sr
2+ sandwiched between every other G-tetrad plane
in the crystal. These studies also identiﬁed formation of
U–U–U–U tetrads, as well as G- and U-containing octads
in the crystal, where uracils pair with the minor groove
edges of guanines of the G-tetrad. Additional aspects of
quadruplex structure have emerged from the 1.4A ˚ crystal
structure of d(
brU)-r(GAGGU) (181) and 1.5A ˚ crystal
structure of r(U)-d(
brG)-r(AGGU) (180). These studies
unequivocally demonstrate formation of Na
+ cation-
coordinated all anti A–A–A–A tetrads involving
either N
6H   N
7 (former quadruplex) or N
6H   N
3
(latter quadruplex) hydrogen-bonding alignments. More
recently, a crystal structure of r(UGGUGU) established
an even higher order architecture associated with a dimer
of quadruplexes scaﬀold (6).
Oncogenic 5’-UTRregions
Bioinformatic searches for guanine-rich sequences in
50-UTRs of the human genome has recently identiﬁed up
to 3000 putative G-quadruplex-forming elements (196).
One of these sequences, an 18-mer containing four
guanine-tracts
50-G1GGAG5GGGCG10GGUCU15GGG-30
is associated with the 50-UTR of the oncogenic N-ras
sequence, located 14-nucleotides downstream of the 50-cap
and 222-nucleotides upstream of the translation start site.
This sequence, which contains four guanine-tracts is
highly conserved across species, both within the guanine-
rich segments and its position relative to the translation
start site, and forms a G-quadruplex (as monitored by cd)
as a function of monovalent cation. The measured tm was
638C in 1mM K cation, and the stabilization decreased
in the order K
+>Na
+>Li
+ (196). The RNA
G-quadruplex was very stable since unfolding was
not observed even at 95C in K
+ solution. The CD
spectrum exhibited characteristics of a parallel-stranded
G-quadruplex with a positive peak at 263nm and a
negative peak at 241nm. The authors used a cell-free
translation system coupled to a reporter gene assay to
demonstrate that the N-ras G-quadruplex inhibits gene
expression at the translational level (196). This seminal
result opens opportunities for the identiﬁcation of small
Nucleic Acids Research, 2007, Vol. 35, No. 22 7443molecule therapeutic agents with the potential for
stabilizing 50-UTR RNA G-quadruplex formation,
thereby inhibiting translation of oncogenes.
FUTURE OPPORTUNITIES: QUADRUPLEX
STRUCTURE
There remain many structural challenges associated with
G-quadruplex architecture, as well as the impact of
structure on function. Several of these are outlined below.
Quadruplexes containing G–A–G–A tetrads
To date there is no evidence for formation of all-purine
major groove-aligned G–A–G–A tetrads within a quad-
ruplex scaﬀold. The design and identiﬁcation of G–A–G–
A tetrads would expand the repertoire of sequences that
can form quadruplex scaﬀolds. There are several possibi-
lities for non-canonical G–A pairing alignments stabilized
by two hydrogen bonds. These include G(anti)–A(anti)
pairing along their Watson–Crick edges (197–199),
sheared G(anti)–A(anti) pairing using the minor groove
edge of G and major groove edge of A (200,201), G(anti)–
A(syn) pairing using the major groove edge of A (202),
and G
+(syn)–A(anti) pairing using the major groove edge
of protonated G (203,204). Such G–A non-canonical pairs
could potentially align along their major groove edges
to form G–A–G–A tetrads. It remains to be demonstrated
whether G–A–G–A tetrad alignments can be accommo-
dated in an otherwise G–G–G–G tetrad-containing
G-quadruplex. The G–A–G–A tetrad has only two
inwardly pointing carbonyls in contrast to four inwardly
pointing carbonyls in the G–G–G–G tetrad available for
monovalent cation coordination. Thus, the role of
monovalent cations in stabilization of G–A–G–A tetrads
is less clear at this time. It should be noted that ethanol
can substitute for monovalent cations in facilitating
quadruplex formation (205).
It is conceivable that the Friedrich’s ataxia d(GAA)n
triplet-repeat sequence (166) could adopt a quadruplex
scaﬀold stabilized by G–A–G–A and A–A–A–A tetrads.
It remains to be established whether such a quadruplex
forms in solution, and if so, what the strand directional-
ities and which tetrad alignments deﬁne the topology.
Quadruplex–quadruplex junctions
Published structural eﬀorts to date have focused on
human telomeres containing one (4), two (17,94), three
(96) and four repeats (9,17,99–106). However, there are
interesting questions concerning (TTAGGG)n repeats,
where n is >4, especially regarding the issue of whether
adjacent human telomeric G-quadruplexes stack on each
other (17), thereby adopting a beads-on-a-string architec-
ture (206). In addition, in a particularly innovatively
designed experiment, it has been shown that chiral cyclic-
helicene molecules of a particular size, which are capable
of wedge formation, can target quadruplex–quadruplex
junctions and stabilize higher order human telomere
structures (207). Both the architecture of quadruplex–
quadruplex junctions and their complexes with ligands
such as chiral cyclic-helicene constitute a signiﬁcant
challenge for the future.
Quadruplex–duplex junctions
In contrast to signiﬁcant progress on the structures of the
G-quadruplex folds of the c-myc (126,128,129) and c-kit
(135) sequences in K
+ solution, and the human telomere
sequence in Na
+ (9) and K
+ (96,99–106) solution, little is
known about the architecture and stability of quadruplex–
duplex junctions, as would occur in a natural context,
where telomeric G-quadruplexes could either cap the ends
of the telomere or where telomeric and oncogenic pro-
moter G-quadruplexes extrude out of a duplex segment.
Studies of G-quadruplex–duplex junctions and their
stability represent a signiﬁcant structural challenge that
will require a systematic investigation involving variations
in the length and sequence of junctional residues.
Telomere t-loops
Electron microscopy studies demonstrate that the telo-
meric G-overhang segment of chromosomal termini may
adopt a non-linear conﬁguration through formation of a
lariat-shaped t-loop structure, where the overhang seg-
ment invades an adjacent duplex region through forma-
tion of a displacement D-loop (Figure 4c) (97). It should
be noted that such a t-loop architecture has the potential
for sequestering and protecting the 30-terminii of telomere
overhangs. Structural studies have the opportunity
to discriminate between proposed alternate models of
t-loop formation.
Oncogenic VEGF andHIF-1aDNA promoters
Both the VEGF and HIF-  promoter sequences (see earlier
VEGF and HIF-1  sequences section) contain ﬁve
guanine-tracts and hence may adopt more than one
conformation in solution. Perhaps, through judicious
choice of single inosine for guanine substitutions, high-
quality NMR spectra corresponding to a single
G-quadruplex conformation may be achievable for each
of these oncogenic promoter sequences, as was success-
fully achieved previously for the ﬁve guanine-repeat
c-myc-23456 G-quadruplex (129).
It should be noted that there are two examples of single
bases separating G-tracts in both the VEGF and HIF-1 
promoters, and these are potential sites for double-
chain-reversal loops (7,16,126). Indeed, there are some
similarities in the sequence between VEGF-1234 and HIF-
1 –2345 in that they have an approximate consensus
element
GGGGNGGG(G)NN(N)GGGGGNGGG(G)
with footprinting studies indicating that this represents a
common structural motif (112,113).
Oncogenic 5’-UTR RNAs
To date, no structures have been reported for oncogenic
50-UTR RNA sequences. Potential candidates containing
four guanine-tracts that impact on oncogenic events (196),
include the 50-UTR of N-ras (see earlier Oncogenic
7444 Nucleic Acids Research, 2007, Vol. 35, No. 2250-UTR regions section for sequence), as well as the
50-UTR of Friend leukemia integration protein 1 (ﬂi1),
which exhibits the sequence
50-GGGAGGGCCCAGGGCGCCAGGG-30
the 50-UTR of apoptosis regulator (bcl-2), which exhibits
the sequence
50-GGGGGCCGUGGGGUGGGAGCUGGGG-30
and the 50-UTR of transcription factor AP1 (jun), which
exhibits the sequence
50-GGGGAGGGGACCGGGGAAGAGAGGG-30
Each of these sequences contains single-residue linkers
with the potential for formation of double-chain-reversal
loops. One can anticipate that several unanticipated
topologies are likely to emerge for RNA quadruplexes,
as reported previously for DNA quadruplexes (35).
Furthermore, unlike oncogenic promoter DNA quadru-
plexes whose formation requires prior melting of the
duplex segment, no such constraint exists for the primarily
unstructured 50-UTR RNA sequences.
Quadruplexes in livingcells
The ultimate challenge would be to develop methods for
probing structures and conformational transitions invol-
ving G-quadruplexes in living cells. Given the rich
diversity of G-quadruplex scaﬀolds and their propensity
to interconvert, it will be a challenge to identify small
molecules that exhibit recognition selectivity for distinct
scaﬀolds at the cellular level. Clearly, one anticipates
further developments, for instance of ﬂuorescent dyes,
along the lines of the carbazole BMVC (65), to further
address this problem.
DRUGS TARGETED TO G-QUADRUPLEX
SCAFFOLDS
The ribonucleoprotein enzyme telomerase, composed of
an endogenous RNA template and a reverse transcriptase,
can maintain telomere length by adding TTAGGG
repeats to the 30-ends of chromosomes (79,208).
Telomerase is active in the majority of human tumor
cells and requires single-stranded telomere ends as a
primer for its activity (84,209). In this regard, telomerase
levels correlate with cancer progression and the meta-
static state. Telomerase activity can be negatively regu-
lated in vivo through monovalent cation-mediated
G-quadruplex formation at telomeric ends (210),
and hence small molecules that bind and stabilize
G-quadruplex structures constitute potent telomerase
inhibitors. This concept was ﬁrst validated when it was
demonstrated that 2,6-diamidodianthraquinone inhibits
the activity of telomerase by interacting with and
stabilizing G-quadruplex structures (211). Some ligands
could also act as molecular chaperones by increasing the
association constant for G-quadruplex formation (212).
G-quadruplex formation denies access of telomerase and
telomeric DNA-binding proteins to telomere overhangs,
thereby selectively interfering with telomere maintenance
in tumor cells (87,88,213–218). Overall, telomerase inhibi-
tion leads to telomere-length reduction, tumor-cell senes-
cence and ultimately apoptosis.
Diverse families of compounds have been identiﬁed that
exhibit selectivity for G-quadruplexes over their duplex
counterparts and inhibit telomerase action in human
tumor cell lines with IC50 values in the sub-mM range.
Many of these compounds contain polyaromatic hetero-
cyclic ring systems, including anthraquinones, acridines,
perylenes and porphyrins (215,216,219,220), capable of
extensive p-stacking interactions with terminal G-tetrads
(221,222), and in some cases containing at least two side
chains directed towards the G-quadruplex grooves. Some
insights into the principles of ligand-G-quadruplex recog-
nition have emerged from the few published NMR and
X-ray structures of complexes.
Polyaromatic heterocyclic rings
NMR studies of complexes formed between the single-
repeat human telomere sequence d(TTAGGGT) and
dicationic perylene tetracarboxylic diimide (223) and
ﬂuorinated pentacyclic quino[4,3,2-kl]acridinium cation
(224) ligands, establish that these polycyclic ring systems
interact with the all-parallel tetramolecular G-quadruplex
through end-stacking over terminal G-tetrads. To date,
despite occasional claims, there is no deﬁnitive spectro-
scopic and structural evidence that supports intercalation
of polycyclic ring system-containing chromophores
between G-tetrads of G-quadruplexes.
An X-ray structure has been reported for the antitumor
drug daunomycin (Figure 13a) bound to the all-parallel-
stranded tetramolecular G-quadruplex formed by
d(TGGGGT) (Figure 14a) (222). Daunomycin aligns in
a trimeric arrangement, with its anthracycline chromo-
phores optimally end-stacked on the terminal G-tetrad
(Figure 14b). In addition, the daunosamine sugar rings are
positioned in the grooves and anchored through inter-
molecular hydrogen bonds.
One of the best-characterized telomerase inhibitors
belongs to the family of 3,6,9-trisubstituted acridine
molecules. The ﬁrst-generation compound, BRACO-19,
exhibits cell growth arrest, chromosomal end-to-end
fusions (225) and antitumor activity in tumor xenografts
(226), all within a short exposure time. BRACO-19 also
induces G-quadruplex formation by competing with
hPOT1 for binding to single-stranded telomeric overhangs.
Such uncapping of telomerase from telomere ends, induces
a rapid DNA damage response and selective cell death.
More recently, the key anilino substitutent in BRACO-19
has been replaced by a benzylamino substitutent
(Figure 13b) resulting in enhanced quadruplex interaction
and superior telomerase inhibitor activity (227).
The X-ray structure of a disubstituted aminoalkylamido
acridine bound to two-repeat Oxytricha
d(GGGGTTTTGGGG) sequence establishes that the
acridine ring system end-stacks with the terminal
G-tetrad of the bimolecular G-quadruplex (Figure 14c)
(221). The acridine ring threads through the diagonal loop
of the bimolecular G-quadruplex, with stacking and
Nucleic Acids Research, 2007, Vol. 35, No. 22 7445intermolecular hydrogen-bonding interactions stabilizing
complex formation (Figure 14d).
Malignant glioblastomas are very aggressive and
invasive tumors of the central nervous system that are
highly refractive to surgery, radiotherapy and chemother-
apy. A family of bisquinolinium-substituted 2,6-pyridine-
dicarboxamide derivatives were shown to inhibit cell
proliferation at low doses and induce massive apoptosis
in cultures of glioma cell lines (228). The apoptosis was
preceded by multiple cell cycle alterations associated with
telomere end fusion and anaphase bridge formation,
suggesting that these pyridine-based G-quadruplex
ligands could serve as promising agents against
malignant gliomas. Furthermore, recent improvements
within this family of G-quadruplex-binding ligands
have resulted following replacement of the central
pyridine-based core by a phenanthroline core (229).
These bisquinolinium-substituted phenanthroline
compounds (Figure 13c), which also adopt a planar
crescent-shaped alignment due to internally organized
hydrogen-bonded syn–syn conformation, exhibit high
aﬃnity and excellent selectivity for the four-repeat
human telomere G-quadruplex. The current model of
complex formation involves stacking of the planar ligands
on terminal G-tetrads of G-quadruplexes, given that
the crescent-shaped ligand exhibits excellent geometric
complementarity with the dimensions of the G-tetrad.
Porphyrins
Porphyrins have been used successfully as ligands
for targeting G-quadruplexes (214,230,231). The most
extensively studied cationic porphyrin has been 5,10,
15,20-tetrakis-(N-methyl-4-pyridyl)porphyrin (TMPyP4)
(Figure 13d), which induces telomerase inhibition upon
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regulates the expression of the c-myc oncogene (111).
NMR-based approaches have been used to investigate
the complex of TMPyP4 with the ﬁve guanine-tract-
containing c-myc-23456 G-quadruplex (129). Large upﬁeld
shifts are observed for a subset of imino proton resonances
on complex formation, with slow exchange between free
and bound forms. Exchange cross peaks observed in the
NOESY spectrum of a sample containing equal amounts
of free and bound forms, allowed assignments of the imino
protons of the complex based on the known assignments in
the free form. The TMPyP4 porphyrin ring stacks towards
one end of the G-quadruplex in the solution structure of
the complex (129).
Recently, an X-ray structure has been solved of
TMPyP4 bound to the all-parallel-stranded bimolecular
G-quadruplex formed by the two-repeat human telomere
d(TAGGGTTAGGG) sequence in K
+ solution
(Figure 14e) (233). Somewhat unexpectedly, the porphyrin
rings do not stack on the terminal G-tetrads, but rather
stack on the TTA nucleotides, both on base pairs formed
at the 50-ends of the G-quadruplex (Figure 14f), as well as
the double-chain-reversal or propeller loops that span the
grooves of the structure. In addition, the propeller loops
undergo a conformational transition on complex
formation.
A limitation of ﬁrst-generation cationic porphyrins such
as TMPyP4 is that they exhibit poor selectivity between
G-quadruplex and duplex DNA. To overcome this
limitation, studies were extended to a Mn(III)-coordinated
porphyrin containing a central aromatic core and four
relatively ﬂexible arms carrying cationic end groups
(Figure 13e). The binding of this Mn(III) porphyrin
to the four-repeat human telomere DNA established
that it targets the human telomere G-quadruplex by
four orders of magnitude over duplex DNA (234).
Furthermore, telomerase inhibition occurred with
IC50 = 580nM. A working model has been put forward
for this remarkable selectivity, where the porphyrin is
proposed to stack on terminal tetrads and the ﬂexible
(a)
(c)
(e)
(b)
(d)
(f)
Figure 14. (a) X-ray structure of the complex of three molecules of daunomycin (in red) bound to the tetramolecular d(TGGGGT) G-quadruplex
(coordinates deposition: 1O0K) (222). (b) Overlap of daunomycin molecules over the terminal G-tetrad. (c) X-ray structure of the complex of
disubstituted aminoalkylamido acridine (in red) bound to the bimolecular d(G4T4G4) G-quadruplex (coordinates deposition: 1L1H) (221).
(d) Overlap of the substituted acridine over the terminal G-tetrad. (e) X-ray structure of the porphyrin TMPyP4 (in red) bound to the d(TAG3T2AG3)
bimolecular G-quadruplex (coordinates deposition: 2HRI) (233). (f) Overlap of the porphyrin ring of TMPyP4 with a terminal base pair.
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Since the substituted Mn(III) porphyrin has two axial
ligands, one of these would have to be replaced by a
Mn-bound water molecule that in turn could potentially
insert into the central channel in the complex (234).
Macrocyclic torands
One of the most promising telomerase inhibitor candi-
dates is telomestatin (Figure 13f), a macrocyclic torand
natural product isolated from Streptomyces anulatus,
consisting of seven oxazole rings and one thiazole ring
that targets G-quadruplexes with high speciﬁcity
(IC50=5nM) (235), causing growth arrest, apoptosis
and telomere dysfunction (236). Furthermore, telomesta-
tin shows selectivity for cancer cell lines over normal cells,
activates key components of the DNA damage-response
pathway and sensitizes tumor cells to chemotherapeutic
agents (237). Telomestatin may also exhibit selectivity,
since it has been suggested that telomestatin and related
macrocycle Se2SAP bind preferentially to diﬀerent folds
of the human telomere G-quadruplex (238). These results
suggest that the equilibrium between conformational
states of the human telomere G-quadruplex can poten-
tially be shifted on complex formation with speciﬁc
macrocyclic ligands.
Oxazole-based peptide macrocycles represent a new
class of chemically synthesized G-quadruplex-binding
ligands (239,240) as analogs of telomestatin. One of
these, an oxazole-containing 24-membered macrocycles
consisting of a hexazole designated HXDV (Figure 13g),
inhibits the growth of human lymphoblastoma cells with
an IC50 of 0.4mM (240). HXDV binds and thermally
stabilizes the structure of the four-repeat human telomere
in K
+ solution, but not to duplex or triplex DNA (241).
The binding stoichiometry is two HXDV molecules per
G-quadruplex, presumably consistent with stacking of the
cyclic hexazoles on the terminal G-tetrads at either end of
the G-quadruplex. Thermodynamic and mobility studies
demonstrate that the binding of HXDV is entropically
driven, with the entropic driving force reﬂecting contribu-
tions from favorable drug-induced alteration in the
conﬁgurational entropy of the DNA (241). A challenge
in all these studies is linking quadruplex binding to
biological eﬀects at the cellular level, as has been
documented to date for BRACO-19 and telomestatin.
Shape-selective recognition
Many of the drug–G-quadruplex complexes solved to date
emphasize recognition principles highlighting the contri-
butions of intermolecular stacking, hydrogen-bonding
and hydrophobic interactions at the expense of shape-
complementarity to recognition. Nevertheless, shape-
selective recognition represents a promising area for
future growth, with some very elegant demonstrations
attesting to its potential for G-quadruplex recognition.
The non-planar and non-aromatic steroid diamines
have long been of interest as potential nucleic acid-binding
ligands since they have been postulated to bind to and
stabilize kink sites in DNA (242). Experimental support
for this hypothesis emerged following NMR
demonstration of partial insertion of the steroid diamine,
dipyrandium, between unstacked base pairs of poly
(dA–dT) (243). Most importantly, a temperature melting
ﬂuorescence-based screen of natural and synthetic mole-
cules identiﬁed two steroid diamines, malouetine and
funtumine that induce G-quadruplex stabilization (244).
Of the two, funtumine substituted by a guanylhydrazone
moiety (Figure 13h), is more promising, since it interacted
selectively in vitro with human telomeric G-quadruplex.
Funtumine-induced senescence and telomere shortening,
as well as rapid telomeric G-overhang degradation and
anaphase bridge formation, associated with uncapping of
telomeric ends. These new results on ﬁrst-generation
steroid diamines hold promise for the future, given that
they can be easily synthesized and modiﬁcations readily
incorporated, in eﬀorts to increase the selectivity and
potency for human telomere G-quadruplex targets.
Recently, chiral cyclic-helicene molecules have been
shown to exhibit chiral and selective binding to higher
order structures by wedging between two adjacent four-
repeat intramolecular human telomere G-quadruplexes
connected by a TTA linker (207). A left-handed chiral
cyclic-helicene with a short linker (Figure 13i) appears to
be sandwiched within a chiral cleft formed by two human
telomere G-quadruplexes stacked 30-to-50 with a connect-
ing TTA loop in d[AGGG(TTAGGG)7], as monitored by
cd and ﬂuorescence (helicenes are strongly ﬂuorescent)
studies.
FUTURE OPPORTUNITIES: QUADRUPLEX
RECOGNITION
The current literature on drugs targeted to
G-quadruplexes is primarily restricted to planar aromatic
chromophores involved in end-stacking on terminal
G-tetrads in G-quadruplexes (215,216). There remain
many structural challenges associated with G-quadruplex
recognition, as well as their impact on function. Several of
these are outlined below.
Structure-based drug design targetedto G-quadruplex
scaffolds
The Watson–Crick and major groove edges of guanines
are involved in hydrogen bonding within the G-tetrad
alignment (Figure 1a), leaving the minor groove edge
available for further recognition. Indeed, it has been
shown that adenines can pair with G-tetrads to form
A–(G–G–G–G) pentads (FIGURE 11C) (18) and A–(G–G–
G–G)–A hexads (Figure 11d) (16), as a result of non-
canonical G–A pair formation. It is thus conceivable that
successive G-tetrad base edges can be targeted by (A)n-
containing sequence segments. An alternate strategy
has been to prepare conjugates containing quadruplex-
stabilizing acridines linked to oligonucleotides that are
complementary to the human telomere sequence (245).
The four grooves can adopt distinct dimensions based
on the strand directionalities around the G-quadruplex,
thereby oﬀering the possibility of discriminating
between distinct quadruplex types. The grooves are
accessible for edge-wise and diagonal loops but occluded
7448 Nucleic Acids Research, 2007, Vol. 35, No. 22for double-chain-reversal loops. At this time, the
current understanding of quadruplex groove-speciﬁc
recognition is restricted to the interaction between the
aglycone sugar ring and grooves in the daunomycin–
G-quadruplex complex (222). Other promising develop-
ments include identiﬁcation of a group of structurally
related compounds that selectively target quadruplex
grooves as monitored by circular dichroism binding
measurements (246).
The diversity of loops linking G-rich strands in
G-quadruplexes range from edge-wise to diagonal and
double-chain-reversal types. These loops can also vary in
length and sequence (21,22,247,248) and can adopt
distinct conformations stabilized by non-canonical pairs,
triples, triads and mixed tetrads. Thus, loops projecting
from G-quadruplexes serve as promising distinct targets,
as yet unexploited by drug design approaches.
To date, there has been less emphasis on the contribu-
tion of shape-complementarity between ligand and
G-quadruplex to molecular recognition. It has been
demonstrated that shape-speciﬁc complementarity
between ligand and three-helical junction targets is key to
both ribozyme-based catalysis (249) and metallosupramo-
lecular helicate recognition (250). We anticipate that this
will represent a challenging area for future investigation.
CombinatorialapproachestoidentificationofG-quadruplex-
binding drugs
A library-based approach is eventually needed for
unbiased and selectivity-driven identiﬁcation of ligands
that target unique G-quadruplex topologies and discrimi-
nate against closely related counterparts. To this end, the
earliest combinatorial selection approaches generated
carbocyanine–peptide conjugate libraries (251).
Furthermore, ribosomal display has yielded antibody
fragment libraries (62) that exhibit speciﬁcity for diﬀerent
G-quadruplex fold families. Recently, click chemistry has
been used to generate bistriazole ligands to generate
pharmacophores capable of p-stacking interactions with
G-tetrads (252).
Library-based approaches can also be applied to
identify proteins that target G-quadruplexes in a sequence
and structure-speciﬁc manner. To this end, selection
approaches have been used to engineer tandem zinc
ﬁnger proteins that bind G-quadruplex scaﬀolds and
eﬀectively inhibit the activity of telomerase (253,254).
Further development of such library-based approaches
should provide opportunities for modulating processes
from DNA recombination to maintenance of telomere
length and integrity.
Protein–DNA/RNA quadruplexcomplexes
Despite over a decade of structural research on
G-quadruplexes, there is still no structure for a protein–
G-quadruplex complex. This is unfortunate since there is
an extensive literature on proteins that bind G-quad-
ruplexes (44–46), including proteins that either facilitate or
non-catalytically disrupt G-quadruplex formation, as well
as helicases that catalytically unwind G-quadruplexes in
an ATP-dependent manner and nucleases that cleave at
or adjacent to G-quadruplex scaﬀolds. Many of these
proteins bind speciﬁc G-quadruplex scaﬀolds. Therefore,
there is a pressing need to devote eﬀorts at structurally
characterizing complexes of proteins that target
DNA and/or RNA families of G-quadruplexes and
G-quadruplex–duplex junctions.
G-quadruplex forming sequences have also been identi-
ﬁed in alternatively spliced pre-mRNA sequences (71).
One of the most important challenges in the future centers
on determination of the structures of RNA G-quadruplex
scaﬀolds and RNA G-quadruplex–duplex junctions
adopted by alternatively spliced pre-mRNA sequences
on complex formation with bound proteins.
Addendum
A recent paper monitored the conformational transition of
the four-repeat human telomere sequence d[G3(T2AG3)3]
in 150 mM K
+ solution on addition of PEG 200, a
mediator of molecular crowding conditions (255). The
CD spectrum changed from one typical of a (3+1) G-
quadruplex to one typical of an all parallel-stranded G-
quadruplex at 40% (w/v) of added PEG 200. The human
telomere G-quadruplex in K
+ solution containing 40%
PEG 200 exhibited unusual stability and negatively
impacted on polymerase processivity. These data provide
strong support for formation of an all parallel-stranded
G-quadruplex for the four-repeat human telomere in K
+
solution under molecular crowding conditions (255).
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